Fear and distress disorders as predictors of heart disease: a temporal perspective

• Published in: Journal of Psychosomatic Research
• Main Authors: Roest, A.M., de Jonge, Peter, Lim, Carmen, Stein, Dan J., Al-Hamzawi, Ali, Alonso Caballero, Jordi, Benjet, Corina, Bruffaerts, Ronny, Bunting, Brentan, Caldas de Almeida, José Miguel, Ciutan, Marius, De Girolamo, Giovanni, Hu, Chiyi, Levinson, Daphna, Nakamura, Yukio, Navarro Mateu, Fernando, Piazza, Marina, Posada Villa, José, Torres, Yolanda, Wojtyniak, Bogdan J., Kessler, Ronald C., Scott, Kate M.
• Format: Article in Journal/Newspaper
• Language: English
• Published: Elsevier
• Subjects: Trastorns d'ansietat; Depressió psíquica; Por; Cor > Malalties; De la Fuente; Norway; Iceland
• Online Access: http://hdl.handle.net/10230/35911; https://doi.org/10.1016/j.jpsychores.2017.03.015

OBJECTIVE: Few studies have been able to contrast associations of anxiety and depression with heart disease. These disorders can be grouped in fear and distress disorders. Aim of this study was to study the association between fear and distress disorders with subsequent heart disease, taking into account the temporal order of disorders. METHODS: Twenty household surveys were conducted in 18 countries (n=53791; person years=2,212,430). The Composite International Diagnostic Interview assessed lifetime prevalence and age at onset of disorders, and respondents were categorized into categories based on the presence and timing of fear and distress disorders. Heart disease was indicated by self-report of physician-diagnosed heart disease or self-report of heart attack, together with year of onset. Survival analyses estimated associations between disorder categories and heart disease. RESULTS: Most respondents with fear or distress disorders had either pure distress or pure fear (8.5% and 7.7% of total sample), while fear preceded distress in the large majority of respondents with comorbid fear and distress (3.8% of total sample). Compared to the "no fear or distress disorder" category, respondents with pure fear disorder had the highest odds of subsequent heart disease (OR:1.8; 95%CI:1.5-2.2; p<0.001) and compared to respondents with pure distress disorder, these respondents were at a significantly increased risk of heart disease (OR:1.3; 95%CI:1.0-1.6; p=0.020). CONCLUSION: hould be confirmed in prospective studies using objective measures of heart disease. This work was carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative which is supported by the National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481). The ESEMeD project is funded by the European Commission (Contracts QLG5-1999-01042; SANCO 2004123, and EAHC 20081308), the Piedmont Region (Italy)), Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnología, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP). Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013 H20-KOKORO-IPPAN-009, H25-SEISHIN-IPPAN-006) from the Japan Ministry of Health, Labour and Welfare. The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544- H). The Polish project Epidemiology of Mental Health and Access to Care –EZOP Project (PL 0256) was supported by Iceland, Liechtenstein and Norway through funding from the EEA Financial Mechanism and the Norwegian Financial Mechanism.The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220) and by the Robert Wood Johnson Foundation (RWJF; Grant 044708). Dr. Benjet has received funding from the (Mexican) National Council of Science and Technology (grant CB-2010-01-155221)